U. Mullerladner et al., DISTINCT PATTERNS OF IMMUNOGLOBULIN CLASSES AND IGG SUBCLASSES OF AUTOANTIBODIES IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, European journal of gastroenterology & hepatology, 8(6), 1996, pp. 579-584
Objective: The pathophysiological significance of autoantibodies in in
flammatory bowel diseases (IBD) is still unclear. To assess specific i
mmunological abnormalities we examined the distribution and restrictio
n of immunoglobulin classes and subclasses of anti-neutrophil cytoplas
mic antibodies (ANCAs) in ulcerative colitis and of antibodies to panc
reatic juice (APJs) in Crohn's disease. Methods: We tested 62 sera of
patients with ulcerative colitis and 184 sera of patients with Crohn's
disease for their immunoglobulin class and IgG subclass distribution
of ANCAs (in ulcerative colitis patients) and APJs (in Crohn's disease
patients) by fluorescence isothiocyanate (FITC)-labelled anti-human a
ntibodies in an immunofluorescence assay with human granulocytes or pa
ncreas as substrate. Twenty-five patients with Wegener's granulomatosi
s were used for comparison. Results: In ulcerative colitis ANCAs were
found in 74% of the patients. They were predominantly of the Ige (96%)
and IgA class (37%). In Crohn's disease APJs (present in 28% of the c
ases) were of the Ige (98%) and IgA class (71%). ANCAs in ulcerative c
olitis were of the IgG1 (73%) and IgG3 (5%) subclasses, APJs in Crohn'
s disease of the IgG1 (94%), IgG2 (20%) and IgG3 (2%) subclasses. The
immunoglobulin class and IgG subclass distributions of ANCAs and APJs
resembled the changes in total immunoglobulin classes and Ige subclass
es in ulcerative colitis or Crohn's disease. Conclusion: The immunoglo
bulin classes and Ige subclasses of autoantibodies in ulcerative colit
is and Crohn's disease differ from each other and from the distributio
n of autoantibodies in vasculitic diseases (Wegener's granulomatosis,
microscopic vasculitis, systemic lupus erythematosus). These alteratio
ns reflect specific pathophysiological features of ulcerative colitis
and Crohn's disease.